Dietary Intake Tied to Inattention With ADHD
Children eating fewer fruits and vegetables likely to have more severe symptoms of inattention
Attention-Deficit/Hyperactivity Disorder
Nonstimulant ADHD Treatment Option Approved for Adults
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
Warning Letters Sent to Online Pharmacies Illegally Selling Schedule II Stimulants
The FDA urges consumers to buy prescription drugs, such as Adderall, from state-licensed US pharmacies or physicians located in the US.
Prenatal Opioid Exposure Increases Risk for Childhood ADHD
Findings also show elevated risk for ADHD with interactions between multiple substances
New Drugs Approved in 2021
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
Dyanavel XR Oral Tablets Approved for ADHD
Dyanavel XR tablets will be supplied as 5mg, 10mg, 15mg. and 20mg tablets.
PCPs Not Routinely Recommending Early Behavioral Treatment for ADHD
Only 11 percent of preschoolers with ADHD diagnosis or symptoms received referrals for parent training in behavior management
Viloxazine Under Review for ADHD Treatment in Adults
The Food and Drug Administration has accepted for review the supplemental New Drug Application for viloxazine extended-release for the treatment of attention-deficit hyperactivity disorder in adults. The application is supported by data from a multicenter, randomized, double-blind, placebo-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT04016779), which assessed the efficacy and safety of viloxazine in 374 adults…
Most Children Experience Fluctuations in ADHD Symptoms
While nearly one in three will experience points of remission of ADHD symptoms, most experience recurrence over time and few outgrow it
Exposure to Prenatal Antipsychotics Seems Safe
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
